Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China flag China · Delayed Price · Currency is CNY
27.31
+1.73 (6.76%)
Oct 23, 2026, 3:04 PM CST

SHE:002223 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
1,1471,4821,8062,3961,5951,482
Depreciation & Amortization
263.91263.91252.22231.96222.38202.48
Other Amortization
54.554.535.9730.7538.2441.27
Loss (Gain) From Sale of Assets
-1.28-1.28-6.16-555.26-170.7-0.29
Asset Writedown & Restructuring Costs
9.099.0924.9554.6279.430.86
Loss (Gain) From Sale of Investments
-34.15-34.15-23.21-138.82-131.58-118
Provision & Write-off of Bad Debts
3.763.7620.87-9.4912.6627.08
Other Operating Activities
-18.57-8.26-20.574.3-38.1352.77
Change in Accounts Receivable
157.28157.28-13.55169.4495.12308.95
Change in Inventory
-56.78-56.78-23.7462.71-259.43-302.81
Change in Accounts Payable
-358.67-358.67-101.09-375.6853.77-471.42
Change in Other Net Operating Assets
-6.61-6.613.92-5.0350.53-
Operating Cash Flow
1,1581,5031,8162,1272,3051,201
Operating Cash Flow Growth
-40.24%-17.25%-14.61%-7.72%91.88%-57.57%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-93.89-128.98-128.43-132.57-379.37-284.32
Sale of Property, Plant & Equipment
273.875.934.7831.55201.650.72
Cash Acquisitions
----17.08-81.54-318.37
Investment in Securities
-243.55-251.6496.371,764-267.42-1,806
Other Investing Activities
-5,568-6,3471.7889.49108.79579.67
Investing Cash Flow
-5,632-6,652-25.51,735-417.89-1,829

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
---200555.331,492
Total Debt Issued
---200555.331,492
Long-Term Debt Repaid
--20.87-1,207-1,113-49.09-654.39
Total Debt Repaid
-38.52-20.87-1,207-1,113-49.09-654.39
Net Debt Issued (Repaid)
-38.52-20.87-1,207-913.36506.24837.79
Issuance of Common Stock
--7.6199.6-149
Repurchase of Common Stock
-----14.97-349.98
Common Dividends Paid
-1,399-799.01-1,224-660.58-350.81-318.85
Other Financing Activities
-428.72-1.9425.069.16214.43456.74
Financing Cash Flow
-1,866-821.82-2,399-1,465354.89774.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-132.29-51.9816.5424.2136.09-27.82
Net Cash Flow
-6,473-6,023-591.852,4212,378119.36

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,0641,3741,6881,9941,926916.88
Free Cash Flow Growth
-39.91%-18.60%-15.37%3.58%110.01%-57.39%
Free Cash Flow Margin
13.26%17.27%22.31%25.02%27.11%13.30%
Free Cash Flow Per Share
1.061.371.692.011.940.92
Levered Free Cash Flow
-4,215111.27882.671,4471,205725.46
Unlevered Free Cash Flow
-4,211115.02895.631,4841,241744.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
305.41608.33622.82904.42497.29448.59
Change in Working Capital
-266.43-266.43-273.5743.06697.58-487.39